Middle East Pharmacoeconomics and Drug Policy Summit 2025

As healthcare systems evolve, Pharmacoeconomics will remain a key discipline for guiding decisions that optimize outcomes, resource allocation, and the overall sustainability of healthcare.
The MEPDPS 2025: Middle East Pharmacoeconomics and Drug Policy Summit 2025 will take place on 21-22 February at JW Marriott Hotel Marina, Dubai, UAE and has been meticulously crafted to serve as a dynamic platform for thought leaders, policymakers, and key stakeholders to exchange insights, share experiences, in the areas focused on healthcare policy, the HEOR in healthcare decision making, economic evaluations, VBHC, the implications of HTA, responses to Real-World Evidence, collaboration, affordability, and equity in healthcare, that enhance patient outcomes, ensure accessibility to innovative therapies, and contribute to the sustainability of our healthcare infrastructure.

URL:
Website: https://go.evvnt.com/2883774-2?pid=2874

Speakers: Abeer Al Rabayah, Head of the Center for Drug Policy and Technology Assessment (CDPTA) Pharmacy Department, King Hussein Cancer Center (KHCC), Jordan, Chair, International Society of Pharmacoeconomics and Outcomes Research (ISPOR) HTA round table, MENA, Ahmed Al Jedai Founding President, Saudi Society of Clinical Pharmacy, Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, Ministry of Health, KSA, Ahmed Seyam Director, Health Economics, and Health Systems Research - Universal Health Insurance Authority, Egypt, Anas Hamad PhD, MSc, DMS, BPharm, RPh, Director of Pharmacy Department, National Center for Cancer Care and Research; Assistant Professor, College of Pharmacy, Qatar University, Qatar, Fabrizio Gianfrate Professor of Health Economics and Outcome Research, University of Ferrara and LUISS Business School Rome, Italy

Category: Exhibitions | Science, Health and Medicine | Medical and Pharmaceutical